ID
25692
Beschreibung
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced
Stichworte
Versionen (2)
- 10.09.17 10.09.17 -
- 10.09.17 10.09.17 -
Hochgeladen am
10. September 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Beschreibung
Eligibility
Alias
- UMLS CUI-1
- C0013893
Beschreibung
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Beschreibung
healthy between 18 and 55 years
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C3898900
- UMLS CUI [1,2]
- C0001779
Beschreibung
childbearing potential
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3831118
Beschreibung
BMI
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1305855
Beschreibung
informed consent
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschreibung
screening finding
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1409616
Beschreibung
allergy dexamethasone
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0013182
- UMLS CUI [1,2]
- C0011777
Beschreibung
osteoporosis
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0029456
- UMLS CUI [1,2]
- C1141639
Beschreibung
concomitant medication
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2347852
Beschreibung
medical history
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0262926
Beschreibung
medical history
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0205082
Beschreibung
cytochrome P450 3A inducer or inhibitors
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3830625
- UMLS CUI [2]
- C3830624
Beschreibung
herbal or dietary supplements
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0242295
- UMLS CUI [2]
- C1504473
Beschreibung
blood donor
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0005795
Beschreibung
investigational drug
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0013230
Beschreibung
drug screeing
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0743295
Beschreibung
alcohol consumption
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0001948
Beschreibung
smoking
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0543414
Beschreibung
HIV, Hepatitis B or Hepatitis C test positive
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1321876
- UMLS CUI [2]
- C2363788
- UMLS CUI [3]
- C2363789
Ähnliche Modelle
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
C0040223 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])
C0001779 (UMLS CUI [1,2])
C0011777 (UMLS CUI [1,2])
C1141639 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C3830624 (UMLS CUI [2])
C1504473 (UMLS CUI [2])
C2363788 (UMLS CUI [2])
C2363789 (UMLS CUI [3])